{"title": "BRIEF-Corline Biomedical: Results Of First Study Of Drug Candidate Renaparin", "author": "Reuters Staff", "url": "https://www.reuters.com/article/brief-corline-biomedical-results-of-firs-idUKFWN2DN0DM", "hostname": "reuters.com", "description": "* DRUG CANDIDATE RENAPARIN SHOWS GOOD SAFETY PROFILE IN FIRST STUDY ON PATIENTS", "sitename": "Reuters", "date": "2020-06-10", "cleaned_text": "June 10 (Reuters) - Corline Biomedical AB: * DRUG CANDIDATE RENAPARIN SHOWS FIRST STUDY ON PATIENTS * RENAPARIN HAS GOOD RESULTS FOR BOTH PRIMARY AND SECONDARY PHASE 1 ENDPOINTS * NEXT STEP IN DEVELOPMENT OF RENAPARIN EXPECTED TO BE COMMUNICATED IN SEPTEMBER 2020 Source Further company "}